Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2461 AL 2475

A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome

Garcia-Borreguero D, Garcia-Malo C, Granizo JJ, Ferré S.

Mov Disord. 2021 Oct;36(10):2387-2392. doi: 10.1002/mds.28668. Epub 2021 Jun 17.

Telerehabilitation-based trunk exercise training for motor symptoms of individuals with Parkinson's disease: A randomized controlled clinical trial

Vasconcellos LS, Silva RS, Pachêco TB, Nagem DA, Sousa CO, Ribeiro TS.

J Telemed Telecare. 2023 Oct;29(9):698-706. doi: 10.1177/1357633X211021740. Epub 2021 Jun 18.

Palliative Care Intervention Trials for Adults Living With Progressive Central Nervous System Diseases and Their Caregivers: A Systematic Review

Leeper H, Cooper D, Armstrong T.

J Pain Symptom Manage. 2022 Jan;63(1):e88-e110. doi: 10.1016/j.jpainsymman.2021.06.010. Epub 2021 Jun 18.

The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson's Disease

Ren H, Zhai W, Lu X, Wang G.

Front Aging Neurosci. 2021 Jun 3;13:691881. doi: 10.3389/fnagi.2021.691881. eCollection 2021.

A case of drug-induced parkinsonism and tardive akathisia with e1143g polymerase γ mutation-innocent bystander or a culprit?

Idiculla PS, Hussain ST, Siddiqui JH.

J Clin Transl Res. 2021 May 14;7(3):297-301. eCollection 2021 Jun 26.

Short-term effect and its retention of LSVT® BIG on QOL improvement: 1-year follow-up in a patient with Parkinson's disease

Hirakawa Y, Koyama S, Takeda K, Iwai M, Motoya I, Sakurai H, Kanada Y, Kawamura N, Kawamura M, Tanabe S.

NeuroRehabilitation. 2021;49(3):501-509. doi: 10.3233/NRE-210129.

Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial

Duffley G, Lutz BJ, Szabo A, Wright A, Hess CW, Ramirez-Zamora A, Zeilman P, Chiu S, Foote KD, Okun MS, Butson CR.

JAMA Neurol. 2021 Aug 1;78(8):972-981. doi: 10.1001/jamaneurol.2021.1910.

[Progressive supranuclear palsy]

Fedorova NV, Bril EV, Kulua TK, Mikhaylova AD.

Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(5):111-119. doi: 10.17116/jnevro2021121051111.

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial

Videnovic A, Amara AW, Comella C, Schweitzer PK, Emsellem H, Liu K, Sterkel AL, Gottwald MD, Steinerman JR, Jochelson P, Zomorodi K, Hauser RA.

Mov Disord. 2021 Oct;36(10):2408-2412. doi: 10.1002/mds.28702. Epub 2021 Jun 30.

Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT

O’Brien JT, Taylor JP, Thomas A, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane J, Chrysos AE, Bentley A, Barker S, Mason J, Burn D, McKeith I.

Southampton (UK): NIHR Journals Library; 2021 Jul.

Directions of Deep Brain Stimulation for Epilepsy and Parkinson's Disease

Wu YC, Liao YS, Yeh WH, Liang SF, Shaw FZ.

Front Neurosci. 2021 Jun 14;15:680938. doi: 10.3389/fnins.2021.680938. eCollection 2021.

Bilirubin: A Promising Therapy for Parkinson's Disease

Jayanti S, Moretti R, Tiribelli C, Gazzin S.

Int J Mol Sci. 2021 Jun 9;22(12):6223. doi: 10.3390/ijms22126223.

[Non-motor symptoms in Parkinson's disease]

Nielsen NS, Skovbølling SL.

Ugeskr Laeger. 2021 Jul 5;183(27):V01210089.

Will Artificial Intelligence Replace the Movement Disorders Specialist for Diagnosing and Managing Parkinson's Disease?

Landers M, Saria S, Espay AJ.

J Parkinsons Dis. 2021;11(s1):S117-S122. doi: 10.3233/JPD-212545.

Imaging of the human subthalamic nucleus

Alkemade A, Forstmann BU.

Handb Clin Neurol. 2021;180:403-416. doi: 10.1016/B978-0-12-820107-7.00025-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias